Characterization of Elimination Pathways and the Feasibility of Endogenous Metabolites as Biomarkers of Organic Anion Transporter 1/3 Inhibition in Cynomolgus Monkeys
Drug Metabolism and Disposition · 2023
DOI: 10.1124/dmd.123.001277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2023. Verfasst von Renmeng Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Drug Metabolism, Gilead Sciences Inc., Foster City, California. Hauptthemen laut MEDLINE: Probenecid, Organic Anion Transporters. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Drug Metabolism, Gilead Sciences Inc., Foster City, California.
- Drug Metabolism, Gilead Sciences Inc., Foster City, California yurong.lai@gilead.com.
ORCID-Profile: Yurong Lai
Zitieren
APA
Liu, R., Hao, J., Zhao, X., & Lai, Y. (2023). Characterization of Elimination Pathways and the Feasibility of Endogenous Metabolites as Biomarkers of Organic Anion Transporter 1/3 Inhibition in Cynomolgus Monkeys. Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.123.001277
Vancouver
Liu R, Hao J, Zhao X, Lai Y. Characterization of Elimination Pathways and the Feasibility of Endogenous Metabolites as Biomarkers of Organic Anion Transporter 1/3 Inhibition in Cynomolgus Monkeys. Drug Metabolism and Disposition. 2023. doi:10.1124/dmd.123.001277
BibTeX
@article{Liu2023,
author = {Liu, Renmeng and Hao, Jia and Zhao, Xiaofeng and Lai, Yurong},
title = {Characterization of Elimination Pathways and the Feasibility of Endogenous Metabolites as Biomarkers of Organic Anion Transporter 1/3 Inhibition in Cynomolgus Monkeys},
journal = {Drug Metabolism and Disposition},
year = {2023},
doi = {10.1124/dmd.123.001277}
}
EUVIMED